Last reviewed · How we verify
Allergic rhinitis
Approved treatments
- Temaril
- Chlophedianol
- Doxylamin · St. Petersburg Bekhterev Research Psychoneurological Institute
- Bilastin · Charite University, Berlin, Germany
- Rupax · Teikoku Seiyaku
- Tussionex Pennkinetic · Teva
Tussionex Pennkinetic works by binding to opioid receptors in the brain, which helps to reduce pain and congestion. - Drixoral · Merck & Co.
- Hispril · GSK
- Pyribenzamin · Novartis
- Pyrilamine · Impax Labs
- Solu-Cortef · Pfizer
- Semprex-D · Auxilium Pharms Inc
- Propadrine · Alpharma Us Pharms
- Mizollen · Sanofi
- Synalgos-Dc · Caraco
- Phenazoline · Novartis
- Aminoacetic Acid 1.5% In Plastic Container · Baxter
- Cutivate · Teva Pharm
- Cortifoam · Pfizer
- Tussionex Pennkinetic · Bayer
- Hydroxyzine Hydrochloride · Pfizer
- Xyzal · Sanofi
- Omnaris · Takeda Gmbh
Omnaris works by activating the glucocorticoid receptor to reduce inflammation in the airways. - Allegra · Generic (originally Hoechst Marion Roussel/Sanofi)
- Cyproheptadine Hydrochloride
- Unisom · Chattem
- Cortone
- Omnaris · Covis
Omnaris works by binding to the glucocorticoid receptor, which then reduces inflammation in the airways. - Verdeso · Padagis Us
- Norgesic · Hikma
- Intal · Pfizer
- Celestone Soluspan
- Bellozal
- Decadron · Generic (originally Merck)
- Potassium Iodide · Roxane
- Diazolinum
- Marezine · GSK
- Seldane
- Carbaphen
- Deltarhinol
- Flonase · GSK (GlaxoSmithKline)
- Sudafed PE · Generic (multiple manufacturers)
- Phencarol
Phencarol works by blocking the action of histamine, a chemical released by the body during an allergic reaction. - Hismanal
- Perazyl
- Mucinex · Generic (multiple manufacturers)
- Phenergan Vc W/ Codeine · ANI Pharmaceuticals
- Cromoglicate · LEO Pharma
- Beconase Aq
- Flixotide · Mundipharma Research Limited
Clinical guidelines
- FDA label — 1L
temporarily relieves minor aches and pains associated with allergic rhinitis - FDA label — 2L
Methylprednisolone can be used for the control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment. - FDA label — 2L
Methylprednisolone can be used for the control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment. - FDA label — 2L
Methylprednisolone can be used for the control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Allergic rhinitis patent landscape — cliff calendar, originator estates, attackable patents
- Allergic rhinitis treatment landscape brief
- Allergic rhinitis treatment updates RSS
Frequently asked questions about Allergic rhinitis
What drugs treat Allergic rhinitis?
Tracked treatments include Temaril, Chlophedianol, Doxylamin, Bilastin, Rupax, Tussionex Pennkinetic, Drixoral, Hispril.
What is the treatment for Allergic rhinitis?
Standard treatment for Allergic rhinitis includes Temaril, Chlophedianol, Doxylamin, Bilastin, Rupax. See the treatment landscape page for first-line, second-line and salvage options.
What are the treatment guidelines for Allergic rhinitis?
FDA label publishes guidelines for Allergic rhinitis. 4 guideline references tracked.
Related
- Treatment landscape: Allergic rhinitis patent cliff · Allergic rhinitis CI report
- Treatment: Temaril
- Treatment: Chlophedianol
- Treatment: Doxylamin · St. Petersburg Bekhterev Research Psychoneurological Institute
- Treatment: Bilastin · Charite University, Berlin, Germany
- Treatment: Rupax · Teikoku Seiyaku
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing